NCT00479154View on ClinicalTrials.gov

Botulinum Toxin to Treat Restless Legs Syndrome

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2008

Conditions
Restless Legs Syndrome
Interventions
DRUG

Botulinum Toxin A

Maximum dose of 90 units/leg was injected.

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

NCT00479154 - Botulinum Toxin to Treat Restless Legs Syndrome | Biotech Hunter | Biotech Hunter